In addition, the role of SAA1 in pancreatic cancer was demonstrated wherein the knockdown of SAA1 in a human pancreatic cell line (PANC-1) improved response to chemotherapy, reduced epithelial-to-mesenchymal transition and reduced invasive capacity (77). The gene discussed is SAA1; the disease is familial pancreatic carcinoma.